AI Drug Discovery Hits a New Bottleneck: Experimental Validation

AI is accelerating early drug discovery by generating thousands of molecule candidates, but experimental validation capacity is now the bottleneck, requiring enhanced laboratory automation and integrated validation processes.

This Wire brief sits within Fusion42's coverage of Drug Discovery, AI Infrastructure and Biotech.